PGY2 Banner University Tucson Oncology Specialty Residency

The PGY2 Oncology Pharmacy Residency Program at Banner - University Medical Center Tucson is a 12-month program for training residents with an interest in oncology, hematology, stem cell transplant, and investigational drug research. The program was established in 2016 and currently has one PGY2 oncology resident. This program is currently in accreditation candidate status by the American Society of Health-System Pharmacists (ASHP). Upon successful completion of the residency program, a certificate will be awarded to the resident by The University of Arizona College of Pharmacy, The University of Arizona Cancer Center and Banner - University Medical Center Tucson.

The PGY2 Oncology Pharmacy Residency provides a well-rounded experience in acute and ambulatory medical oncology, hematology, and stem cell transplant. The PGY2 oncology resident will be actively involved in the therapeutic decision-making process and clinical outcomes for cancer patients. In addition, the resident will gain experiences in teaching, precepting, clinical research and quality improvement. The residency is designed to instill a philosophy that denotes an oncology pharmacy practice model focusing on accountability for optimal drug therapy according to the pharmaceutical care model. The resident will also be prepared for board certification in oncology pharmacy upon completion of this residency.

  • National Matching Services Code: 81015
  • Duration/Type: 12-month residency
  • Number of positions: One
  • Salary: $52,000
  • Application deadline: January 5
  • How to Apply

Patient Care Learning Experiences

Required Rotations

  • Oncology Pharmacy Orientation
  • Ambulatory Breast Oncology
  • Ambulatory Gastrointestinal Oncology
  • Ambulatory Head, Neck, and Thoracic Oncology
  • Ambulatory Hematologic Malignancies
  • Ambulatory Melanoma and Sarcoma
  • Ambulatory Gynecologic Oncology
  • Inpatient Adult Hematology and Oncology
  • Inpatient Leukemia and Hematopoietic Stem Cell Transplant (HSCT)
  • Investigational Drug Services
  • Specialty Pharmacy

Elective Rotations (Select 2)

  • Adult Oncology Palliative Care and Hospice
  • Ambulatory Genitourinary Oncology
  • Pediatric Hematology, Oncology, and BMT


  • Drug Information Oncology
  • Oncology Administrative Forum
  • Oncology Chemotherapy Operations
  • Pharmacy Residency Project
  • Oral Antineoplastic Program

Our program participates in the American Society of Health-System Pharmacists (ASHP) Residency Matching Program and is fully accredited by ASHP.

Pharmacy Residency Director

Ali McBride, PharmD, MS, BCOP, FASHP, FAzPA
(520) 694-6789